50 articles tagged with "healthcare"
Steve Ubl, the CEO of PhRMA, will resign at the end of the year, marking a notable shift in the pharmaceutical lobbying arena after leading for more than ten years.
The first year of the ACO program, which emphasizes equity and community health, has shown promising results in quality and savings, according to Health Affairs.
A recent analysis highlights the changing landscape of patient cost-sharing practices and their potential effects on the financial health of urban and rural hospitals.
A recent study indicates that Maryland has seen a notable reduction in hospital utilization, outpacing other states by 11 percentage points from 2013 to 2023.
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
Strategic angle: Researchers advocate for urgent licensing of generic production to enhance accessibility.
Strategic angle: Exploring the implications and potential benefits of implementing a Most Favored Nation drug pricing model.
A small biotech company faced a critical setback due to a delayed agreement with the FDA, leading to its closure.
Strategic angle: Neurocrine Biosciences is acquiring Soleno Therapeutics for $2.9 billion, gaining access to a treatment for a rare disease linked to insatiable hunger.
Strategic angle: The reform will introduce digital referrals, a national health insurance fund and a guaranteed package of medical services funded through the state budget.
Strategic angle: Smaller biotechs negotiate with the White House while addressing the trust gap in medicine.
Strategic angle: The daily pill called Foundayo got a fast track through the Food and Drug Administration.
Strategic angle: A new study reveals that AI scribes saved doctors approximately 16 minutes during an eight-hour shift across five academic medical centers.
Strategic angle: Eli Lilly's CEO expresses opposition to the White House's efforts to codify drug pricing reforms.
Strategic angle: The company showcases robust growth prospects driven by its diverse therapeutic offerings.
Strategic angle: An analysis of the current market sentiment surrounding Omega Healthcare Investors, Inc.
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Strategic angle: Exploring the effectiveness of new AI-driven health applications in the market.
The case of a young woman pursuing her right to die has sparked significant national debate in Spain.
Strategic angle: CRISPR's precision in gene editing faces hurdles due to DNA shape complexities.
A significant decision by the FDA following previous rejections of rare disease treatments.
Strategic angle: Eli Lilly discusses the 'societal obligation' of GLP-1s amidst other biotech news.
Strategic angle: Settlement expected to save Americans up to $7 billion in out-of-pocket costs over the next decade.
Strategic angle: An analysis reveals that drugmakers penalized for kickbacks paid only a small fraction of their U.S. revenue from the drugs involved.
Strategic angle: New research finds that an influx of immigrants can significantly reduce elderly mortality rates in metropolitan areas.
Strategic angle: A tiny crystal chip harnesses terahertz radiation for enhanced imaging through various materials, promising advancements in healthcare and security.
Strategic angle: A novel approach to combat antibiotic resistance by disrupting bacterial communication rather than killing the microbes.
Strategic angle: A recent lawsuit by Epic reveals a company allegedly posing as a provider to access patient records, raising concerns over oversight.
Strategic angle: A mother's struggle to secure a life-saving treatment for her son amidst challenges.
Strategic angle: A significant rise in sepsis cases raises questions about the accuracy of hospital billing practices and the role of AI in medical coding.
Strategic angle: In this special edition of The Ring, MEPs debate the funding of European health innovation.
Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives.
Strategic angle: An Australian entrepreneur claims AI helped save his dog, but the story raises questions about the role of technology in healthcare.
Strategic angle: A new AI model offers insights into gene expression changes, potentially transforming drug discovery processes.
Strategic angle: Jay Bhattacharya assures House appropriators that the NIH will utilize its entire budget by the end of the fiscal year 2026.
Strategic angle: The White House intensifies pressure on Congress for drug pricing legislation.
Strategic angle: Families report financial and treatment struggles after GSK's price increases on asthma inhalers.
Strategic angle: CMS has announced a new strategy focusing on pausing or withholding federal funding in potential fraud cases, impacting states and enrollees.
Most Across Political Parties Want Government to Do More to Regulate Prices
Strategic angle: The FDA is scrutinizing telehealth marketing practices for GLP-1 drugs, raising questions about prescribing trends.
Strategic angle: A new nanogel modification could enhance the viability of stem cells for patients with swallowing difficulties.
Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.
Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.
Strategic angle: FDA approves Opill, marking a significant change in access to oral contraceptives in the U.S.
A recent study highlights that most family physicians remain in the states where they trained, raising questions about workforce distribution and healthcare access.
A comprehensive analysis reveals troubling trends in primary care physician satisfaction in the US and nine comparator nations, indicating systemic issues that could affect healthcare outcomes.
Recent findings suggest that while private equity is driving investment in primary care, clinician growth is tempered by a notable increase in exits.
A study spanning 2000 to 2021 reveals concerning mortality trends among SSDI beneficiaries awaiting Medicare, highlighting systemic healthcare risks.
A recent study highlights the complex dynamics between labor unions and nurse staffing ratios in US nursing homes, with implications for care quality.
The World Health Organization's confirmation of 13 attacks on healthcare sites in Iran raises critical concerns regarding the implications for healthcare safety in conflict zones.